These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 5878307)

  • 41. The origin of complete and mosaic mutants from mutagenic treatment of single cells.
    Nasim A; Auerbach C
    Mutat Res; 1967 Feb; 4(1):1-14. PubMed ID: 6027474
    [No Abstract]   [Full Text] [Related]  

  • 42. Effect of some fungicides and antibiotics on sclerotial development and germination of ergot on Pennisetum typhoideum.
    Sulaiman M; Lukade GM; Dawkhar GS
    Hindustan Antibiot Bull; 1966 Nov; 9(2):94-6. PubMed ID: 5975727
    [No Abstract]   [Full Text] [Related]  

  • 43. Synthesis and SAR studies of novel antifungal 1,2,3-triazines.
    Hunt JC; Briggs E; Clarke ED; Whittingham WG
    Bioorg Med Chem Lett; 2007 Sep; 17(18):5222-6. PubMed ID: 17656087
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The production, by nitrous acid, of complete and mosaic mutations during defined nuclear stages in cells of Schizosaccharomyces pombe.
    Abbondandolo A; Bonatti S
    Mutat Res; 1970 Jan; 9(1):59-69. PubMed ID: 5410810
    [No Abstract]   [Full Text] [Related]  

  • 45. Calcineurin inhibition or mutation enhances cell wall inhibitors against Aspergillus fumigatus.
    Steinbach WJ; Cramer RA; Perfect BZ; Henn C; Nielsen K; Heitman J; Perfect JR
    Antimicrob Agents Chemother; 2007 Aug; 51(8):2979-81. PubMed ID: 17502415
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Relation of cell wall growth and conjugation to the cell division cycle in Schizosaccharomyces pombe].
    Shtreĭblova E
    Mikrobiologiia; 1977; 46(4):717-24. PubMed ID: 909471
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Use of biochemical parameters for the individuation of genetic variants: study of the relative efficiency of some parameters determined on a number of mutants of Schizosaccharomyces pombe with altered acid phosphatase activity.
    Bauer C; Cinci A; Bronzetti G; Loprieno N
    Biochem Genet; 1974 Jan; 11(1):1-15. PubMed ID: 4817527
    [No Abstract]   [Full Text] [Related]  

  • 48. The role of lethal sectoring in the origin of complete mutations in Schizosaccharomyces pombe.
    Guglielminetti R
    Mutat Res; 1968; 5(2):225-9. PubMed ID: 5672967
    [No Abstract]   [Full Text] [Related]  

  • 49. Analysis of the mosaicism induced by hydroxylamine and nitrous acid in Schizosaccharomyces pombe.
    Guglielminetti R; Bonatti S; Loprieno N; Abbondandolo A
    Mutat Res; 1967; 4(4):441-7. PubMed ID: 6059025
    [No Abstract]   [Full Text] [Related]  

  • 50. Structure and biosynthesis of heat-stable antifungal factor (HSAF), a broad-spectrum antimycotic with a novel mode of action.
    Yu F; Zaleta-Rivera K; Zhu X; Huffman J; Millet JC; Harris SD; Yuen G; Li XC; Du L
    Antimicrob Agents Chemother; 2007 Jan; 51(1):64-72. PubMed ID: 17074795
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Derivatives of 4-nitroso-aminopyrazole as antifungal agents].
    Giori P; Mazzotta D; Vertuani G; Guarneri M; Pancaldi D; Brunelli A
    Farmaco Sci; 1981 Dec; 36(12):1019-28. PubMed ID: 7319023
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cell wall composition plays a key role on sensitivity of filamentous fungi to chitosan.
    Aranda-Martinez A; Lopez-Moya F; Lopez-Llorca LV
    J Basic Microbiol; 2016 Oct; 56(10):1059-1070. PubMed ID: 27259000
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Problems and hopes in the development of drugs targeting the fungal cell wall.
    Aimanianda V; Latgé JP
    Expert Rev Anti Infect Ther; 2010 Apr; 8(4):359-64. PubMed ID: 20377329
    [No Abstract]   [Full Text] [Related]  

  • 54. Glucose superrepressed and derepressed respiratory mutants in a "petite-negative" yeast: Schizosaccharomyces pombe 972h.
    Foury F; Goffeau A
    Biochem Biophys Res Commun; 1972 Jul; 48(1):153-60. PubMed ID: 5041874
    [No Abstract]   [Full Text] [Related]  

  • 55. In vitro antifungal susceptibility of clinical isolates of Arthrographis kalrae, a poorly known opportunistic fungus.
    Sandoval-Denis M; Giraldo A; Sutton DA; Fothergill AW; Guarro J
    Mycoses; 2014 Apr; 57(4):247-8. PubMed ID: 24147779
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Optimisation of an in vitro antifungal protein assay for the screening of potential antifungal proteins against Leptosphaeria maculans.
    Pillay V; Polya GM; Spangenberg GC
    J Microbiol Methods; 2011 Jan; 84(1):121-7. PubMed ID: 21093501
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cordycepin in Schizosaccharomyces pombe: effects on the wild type and phenotypes of mutants resistant to the drug.
    Naula N; Hilti N; Schweingruber AM; Schweingruber ME
    Curr Genet; 2003 Sep; 43(6):400-6. PubMed ID: 12827445
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In vitro activities of antifungal drugs against Rhinocladiella mackenziei, an agent of fatal brain infection.
    Badali H; de Hoog GS; Curfs-Breuker I; Meis JF
    J Antimicrob Chemother; 2010 Jan; 65(1):175-7. PubMed ID: 19854862
    [No Abstract]   [Full Text] [Related]  

  • 59. Synthesis and evaluation of antifungal activity of C21-steroidal derivatives.
    Huang LJ; Wang B; Zhang JX; Yuan CM; Gu W; Mu SZ; Hao XJ
    Bioorg Med Chem Lett; 2016 Apr; 26(8):2040-3. PubMed ID: 26947608
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Transformation of auxotrophic mutants of group H streptococci.
    Leonard CG; Corley D; Cole RM
    Science; 1966 May; 152(3726):1255-6. PubMed ID: 5937115
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.